Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
87 participants
OBSERVATIONAL
2013-01-01
2020-12-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevalence of Keratoconus in Inflammatory Bowel Diseases
NCT02861339
Renal and Urinary Manifestations of Chronic Inflammatory Bowel Diseases.
NCT06814392
Utilization of NBi in Assessing Luminal INflammaion in IBD (UNBLIND)
NCT02049775
Intestinal Bacteria and Ocular Inflammatory Disease
NCT01859299
Magnification Endoscopy and Electronic Chromoendoscopy in Patients With Inflammatory Bowel Disease
NCT03536091
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with chronic inflammatory bowel disease who consulted in ophthalmology
reason for consultation
search in medical files for reasons for ophthalmology consultation, functional signs, clinical signs, treatment, characteristics of IBD
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
reason for consultation
search in medical files for reasons for ophthalmology consultation, functional signs, clinical signs, treatment, characteristics of IBD
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* patients without IBD
* patients for whom there is no ophthalmology consultation
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Central Hospital, Nancy, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRIPH
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.